CompaniesBrexogen

Brexogen

active
Seoul, Korea
Founded 2019
Website
About

Exosome Therapeutics

Areas of Focus

Categories

Biologics & BiopharmaceuticalDrug Delivery & Formulation
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

45

By Phase

PHASE1: 2

By Status

WITHDRAWN: 1RECRUITING: 1

Recent Trials

NCT06055374Lead Sponsor
A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Repeated-dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
PHASE1Withdrawn
Started: May 1, 2024 · Completed: Aug 30, 2025
NCT06055361Lead Sponsor
A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
PHASE1Recruiting
45 participants
Started: Apr 18, 2023 · Completed: Mar 31, 2026
Locations (1)
Headquarters
Seoul, Korea
Map

Loading map...